Guggenheim Capital LLC Lannett CO Inc Transaction History

Guggenheim Capital LLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$4.17 - $5.74 $247,076 - $340,100	-59,251 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$5.28 - $9.64 $189,240 - $345,507	35,841 Added 153.1%	59,251 $313,000
Q4 2020 Feb 16, 2021	BUY	$5.75 - $7.13 $50,065 - $62,080	8,707 Added 59.22%	23,410 $153,000
Q3 2020 Nov 13, 2020	BUY	$4.9 - $7.12 $72,044 - $104,685	14,703 New	14,703 $90,000
Q1 2020 Jun 02, 2020	SELL	$6.36 - $10.05 $88,976 - $140,599	-13,990 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$8.49 - $12.81 $106,787 - $161,124	-12,578 Reduced 47.34%	13,990 $123,000
Q3 2019 Nov 14, 2019	BUY	$5.58 - $14.47 $148,249 - $384,438	26,568 New	26,568 $298,000
Q2 2019 Aug 14, 2019	SELL	$5.22 - $9.08 $63,094 - $109,749	-12,087 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$5.35 - $9.82 $64,665 - $118,694	12,087 New	12,087 $95,000
Q4 2018 Feb 14, 2019	SELL	$3.43 - $6.19 $217,842 - $393,133	-63,511 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$4.75 - $14.5 $655 - $2,001	138 Added 0.22%	63,511 $302,000
Q2 2018 Aug 14, 2018	SELL	$13.3 - $17.45 $44,182 - $57,968	-3,322 Reduced 4.98%	63,373 $861,000
Q1 2018 May 15, 2018	BUY	$14.7 - $24.95 $20,741 - $35,204	1,411 Added 2.16%	66,695 $1.07 Million
Q4 2017 Feb 14, 2018	SELL	$19.9 - $29.25 $23,283 - $34,222	-1,170 Reduced 1.76%	65,284 $1.52 Million
Q3 2017 Nov 14, 2017	BUY	$15.1 - $19.25 $1 Million - $1.28 Million	66,454	66,454 $1.23 Million

Ticker LCI
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 42,960,000
Market Cap $1.29M
Description
Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nas...

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Guggenheim Capital LLC with notifications on news.